Accenture Backs Turbine's AI-Powered Platform to Accelerate Drug Discovery
Accenture Ventures makes a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.
Source: hitconsultant.net
Patient Selection News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Patient Selection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Patient Selection Today - Breaking & Trending Today
iTWire - Why clinical trial patient recruitment software matters
GUEST OPINION: In the evolving realm of healthcare, technological advancements are profoundly impacting facets of clinical research. A notable domain...
Source: itwire.com
Elacestrant: Adverse Effects and Their Management, and Impact of Treatment on Quality of Life
Experts discuss the impact of elacestrant on patient well-being, including potential cardiovascular and gastrointestinal toxicities, quality of life, and patient feedback regarding access to treatment.
Source: ajmc.com
Elacestrant: Treatment Considerations, Including Dosing and Compliance
Experts explore treatment considerations when treating patients with metastatic breast cancer with elacestrant, including dosing, patient selection, adherence, and treatment duration. Participants also discuss dose modifications, adherence concerns, and how they determine treatment failure.
Source: ajmc.com
Elacestrant in Later-Line Treatment of ER+/HER2– Metastatic Breast Cancer
Experts delve into practical aspects of using elacestrant in later-line treatment of patients with estrogen receptor–positive (ER+)/HER2-negative (HER2–) metastatic breast cancer, including testing for ESR1 mutations, evaluating efficacy, and monitoring for toxicity.
Source: ajmc.com